CSL shares plunge to 7-year low on delay in US vaccine business spinoff
Delano Ladd, Executive Vice President and General Counsel at HealthEquity, Inc. (NASDAQ:HQY), a healthcare technology company with an $8.2 billion market cap and "GREAT" financial health according to InvestingPro, sold 1,500 shares of common stock on October 20, 2025, at a price of $92.07, totaling $138,105. The sale price represents a slight discount to the current trading price of $95.56.
Following the transaction, Ladd directly owns 76,979 shares of HealthEquity, Inc. common stock. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 12, 2025. Notably, while this insider sale occurs, InvestingPro data shows the company maintains a perfect Piotroski Score of 9, indicating strong financial performance, with management actively buying back shares. For deeper insights into insider trading patterns and 11 additional ProTips, consider exploring the comprehensive Pro Research Report available on InvestingPro.
In other recent news, HealthEquity Inc. reported impressive financial results for the second quarter of fiscal year 2026, exceeding analyst expectations. The company achieved an earnings per share of $1.08, surpassing the projected $0.92. Revenue for the quarter reached $325.9 million, outpacing the anticipated $320.74 million. Additionally, HealthEquity has launched a new platform connecting Health Savings Account (HSA) members with GLP-1 weight management medications and introduced a direct HSA enrollment service. These initiatives are timed with National HSA Awareness Day and the open enrollment season. In leadership developments, HealthEquity appointed Mukund Ramachandran as Chief Marketing Officer and Garett Kitch as Senior Vice President of Client Sales & Relationship Management. These appointments align with the company’s preparation for upcoming HSA eligibility expansion. These recent developments highlight HealthEquity’s strategic efforts to enhance its services and leadership team.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.